225 related articles for article (PubMed ID: 36243282)
21. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
Schoepfer A; Safroneeva E; Straumann A
Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
[TBL] [Abstract][Full Text] [Related]
22. Eosinophilic esophagitis: an immune-mediated esophageal disease.
Weinbrand-Goichberg J; Segal I; Ovadia A; Levine A; Dalal I
Immunol Res; 2013 Jul; 56(2-3):249-60. PubMed ID: 23579771
[TBL] [Abstract][Full Text] [Related]
23. Tissue remodeling in eosinophilic esophagitis.
Cheng E; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Eosinophilic Esophagitis: Diet or Medication?
Chehade M; Aceves SS
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3249-3256. PubMed ID: 34507706
[TBL] [Abstract][Full Text] [Related]
25. [Eosinophilic esophagitis: update 2012].
Jo Y
Korean J Gastroenterol; 2012 Jul; 60(1):3-12. PubMed ID: 22832794
[TBL] [Abstract][Full Text] [Related]
26. Successful use of dupilumab for egg-induced eosinophilic gastroenteritis with duodenal ulcer: a pediatric case report and review of literature.
Tsuge M; Shigehara K; Uda K; Kawano S; Iwamuro M; Saito Y; Yashiro M; Ikeda M; Tsukahara H
Allergy Asthma Clin Immunol; 2023 Dec; 19(1):103. PubMed ID: 38053199
[TBL] [Abstract][Full Text] [Related]
27. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.
Khokhar D; Marella S; Idelman G; Chang JW; Chehade M; Hogan SP
Clin Exp Allergy; 2022 Oct; 52(10):1142-1156. PubMed ID: 35778876
[TBL] [Abstract][Full Text] [Related]
28. Eosinophilic esophagitis: review of nonsurgical treatment modalities.
Reddy V; Ghaffari G
Allergy Asthma Proc; 2013; 34(5):421-6. PubMed ID: 23998238
[TBL] [Abstract][Full Text] [Related]
29. Drug treatment strategies for eosinophilic esophagitis in adults.
Lucendo AJ
Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
[TBL] [Abstract][Full Text] [Related]
30. Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders.
Arakawa N; Yagi H; Shimizu M; Shigeta D; Shimizu A; Nomura S; Takizawa T; Yamada Y
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671497
[TBL] [Abstract][Full Text] [Related]
31. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis.
Otani IM; Nadeau KC
Immunol Allergy Clin North Am; 2017 May; 37(2):369-396. PubMed ID: 28366483
[TBL] [Abstract][Full Text] [Related]
32. Eosinophilic esophagitis in adults and adolescents: epidemiology, diagnostic challenges, and management strategies for a type 2 inflammatory disease.
Savarino EV; Barbara G; Bilò MB; De Bortoli N; Di Sabatino A; Oliva S; Penagini R; Racca F; Tortora A; Rumi F; Cicchetti A
Therap Adv Gastroenterol; 2024; 17():17562848241249570. PubMed ID: 38812705
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic esophagitis.
Merves J; Muir A; Modayur Chandramouleeswaran P; Cianferoni A; Wang ML; Spergel JM
Ann Allergy Asthma Immunol; 2014 May; 112(5):397-403. PubMed ID: 24566295
[TBL] [Abstract][Full Text] [Related]
34. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
Ridolo E; Barone A; Ottoni M; Peveri S; Montagni M; Nicoletta F
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338983
[TBL] [Abstract][Full Text] [Related]
35. Emerging therapies for eosinophilic esophagitis.
Greuter T; Hirano I; Dellon ES
J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
[TBL] [Abstract][Full Text] [Related]
36. A Practical Update on Pediatric Eosinophilic Esophagitis.
Votto M; De Filippo M; Caimmi S; Indolfi C; Raffaele A; Tosca MA; Marseglia GL; Licari A
Children (Basel); 2023 Sep; 10(10):. PubMed ID: 37892285
[TBL] [Abstract][Full Text] [Related]
37. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.
Rank MA; Sharaf RN; Furuta GT; Aceves SS; Greenhawt M; Spergel JM; Falck-Ytter YT; Dellon ES; ; ; ;
Gastroenterology; 2020 May; 158(6):1789-1810.e15. PubMed ID: 32359563
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
Arias Á; Lucendo AJ
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
[TBL] [Abstract][Full Text] [Related]
39. Emerging drugs for eosinophilic esophagitis.
Kern E; Hirano I
Expert Opin Emerg Drugs; 2013 Sep; 18(3):353-64. PubMed ID: 23937314
[TBL] [Abstract][Full Text] [Related]
40. Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis.
Lee CJ; Dellon ES
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):252-258. PubMed ID: 37660770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
